The 8,759-Hour Health Blindspot

Most people with a chronic illness spend less than one hour a year in front of a doctor, yet that hour is often treated as the entire treatment plan. A new push from health leaders wants to flip that math, building support systems for the other 8,759 hours patients spend managing their own health at home.

Quick Take

TIME’s 2026 Leadership Forum series highlighted efforts to redesign chronic care around patients’ daily lives, not just office visits
Health experts say psychological support matters as much as medication for chronic illness
Companies like Omada Health argue 80 to 90 percent of health outcomes happen between doctor visits
Decades of research back the general idea, though results vary depending on how programs are built

A New Push To Rethink Chronic Care

TIME published a piece titled “How to Make Chronic Care Fit Into Patients’ Lives” on September 11, 2026, as part of its TIME100 Leadership Forums collection. The article makes a simple but overlooked point. Treating a chronic illness means paying attention to what happens psychologically, not just what shows up on a lab report. That shift in thinking is starting to reshape how care gets delivered across the country.

The old model asks patients to show up, get checked, and follow instructions until the next appointment months later. Anyone who has tried to lose weight, manage diabetes, or lower blood pressure knows how much life happens in between those visits. Work stress, family demands, and plain exhaustion can undo good advice fast. Health leaders now argue that real progress depends on support that travels home with the patient.

The Business Case For Between-Visit Support

Wei-Li Shao, President of Omada Health, has been blunt about the math behind this shift. He points out that between 80 percent and 90 percent of health outcomes are shaped by what happens outside the clinic, not inside it. Omada, founded in 2011, describes itself as an evidence-based virtual care provider that gives patients supplemental support between clinical visits for conditions like diabetes, hypertension, and musculoskeletal pain.

That support looks less like a hospital and more like a coaching relationship. Omada pairs human care teams with technology to keep tabs on patients day to day, aiming for help that is timely, coordinated, and personal rather than a once-a-season checkup. The company recently rolled out a Physician-Guided Care Program that adjusts patient medications directly through a virtual cardiometabolic clinic, cutting down on the number of trips patients need to make to a primary care office.

What The Research Actually Shows

This is not a fringe theory. A 2024 scoping review of chronic disease management models found that programs combining education, coordinated follow-up, and team-based support can improve things like medication adherence and blood sugar control. That is a meaningful finding for the roughly six in ten American adults living with at least one chronic condition, according to federal health data cited across this body of research.

The evidence is not uniform across every setting, and results depend heavily on how a program is designed and who runs it. Some reviews find strong gains in patient adherence and symptom control, while effects on hospital admissions and total cost are less consistent. That nuance matters, but it does not undercut the core logic driving this movement: care built only around scheduled visits leaves most of a patient’s life unsupervised.

Why This Approach Fits American Values

There is something distinctly common-sense about this trend, and it lines up with values many conservatives already hold dear. It favors personal responsibility paired with practical tools, not government mandates dictating how care must be delivered. Private companies are competing to build better support systems because patients and employers are demanding results, not because a federal agency ordered it.

Employers are increasingly offering these between-visit programs as workplace benefits, giving families more choice in how they manage chronic conditions without adding new layers of bureaucracy. That market-driven approach, rewarding companies that actually improve people’s daily lives, is a far more sustainable path than top-down health mandates. It puts the patient and their family back at the center of decision-making, which is exactly where that responsibility belongs.

The bigger takeaway is straightforward. Chronic illness does not pause between doctor visits, and neither should the support meant to manage it. As more health systems and private companies build tools that meet patients where they actually live, work, and struggle, the old model of care built entirely around a fifteen-minute appointment looks increasingly outdated.